Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (ID2018/12857) TLR7 AGONIST TRIFLUOROACETATE SALT AND CRYSTALLINE FORM B THEREOF, PREPARATION METHODS AND USES

Office : Indonesia
Application Number: PID201806779 Application Date: 04.02.2017
Publication Number: 2018/12857 Publication Date: 14.12.2018
Publication Kind : A
Prior PCT appl.: Application Number:PCTCN2017072894 ; Publication Number:WO2017133687 Click to see the data
IPC:
A61K 31/519
A61P 31/12
C07D 487/04
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
Applicants: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors: DING, Zhaozhong
SUN, Fei
HU, Yinghu
ZHOU, Yilong
WANG, Zheng
ZHAO, Rui
YANG, Ling
Agents: Nadia Am Badar, SH.
Priority Data: 201610081899.3 05.02.2016 CN
Title: (EN) TLR7 AGONIST TRIFLUOROACETATE SALT AND CRYSTALLINE FORM B THEREOF, PREPARATION METHODS AND USES
(ID) GARAM TRIFLUOROASETAT AGONIS TLR 7, BENTUK KRITAL B DARIPADANYA, METODE PEMBUATAN DAN PENGGUNAAN
Abstract:
(EN)

The present invention relates to a trifluoroacetate salt of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), crystalline form B of the trifluoroacetate salt, methods for preparing the trifluoroacetate salt and crystalline form B, and uses of the trifluoroacetate salt and crystalline form B.


(ID)

Invensi ini berhubungan garam trifluoroasetat dari agonis TLR7, (2-butoksi-7-(4-(pirolidin-1-ilmetil)benzil)-5H-pirolo [3,2-d}pirimidin-4-amin (formula I), bentuk kristal B dari garam trifluorosetat, metode pembuatan garam trifluoroasetat dan bentuk kristal B, dan penggunaan garam trifluoroasetat dan bentuk kristal B.


Also published as:
UAa201809128AU2017214135CA3013521MYPI 2018702700SG11201806688QKR1020180104118
CN108602833EP3412674IL260981BR112018015878US20190031666IN201817032726
EA201891772PH1/2018/501641WO/2017/133687